Haematology Flashcards
What are lymphomas? Accumulate where causing what? Histologically divided into what 2 types?
Malignant proliferations of lymphocytes
Lymph nodes–> lymphadenopathy, also in peripheral blood or infiltrate organs
Hodgkins- have characteristic cells with mirror-like image nuclei called Reed- Sternberg cells
Non-Hodgkins- do not have characteristic cells, low grade= follicular, high grade= diffuse large B cell, very high grade= Burkitt’s
Aetiology of lymphomas?
Primary immunodeficiency- ataxia telangiectasia, Wiscott- Aldrich syndrome
Secondary immunodeficiency- HIV, transplant recipients
Infection- EBV, human T-lymphotropic virus, helicobacter pylori
Autoimmune disorders e.g. SLE
Signs and symptoms of lymphomas? Investigations into lymphomas?
Stroke, ulcers, nodal/ extra nodal disease, compression syndrome (lump compressing structures,) systemic B symptoms- lump, loss of appetite, weight loss, sweat
FBC, DM, lymph node biopsy, immunophenotyping(antigens,) cytogenetics (karyotyping- chromosomal abnormalities, FISH- translocations,) molecular genetics (PCR- insertions/ deletions,) history and examination, CXR, ECHO, PFT, WHO performance status
Epidemiology and suggested role in pathogenesis? Further divided into what 2 types?
Male predominance, EBV suggested role
Peaks of incidence= teenagers and elderly
Classical (cHL)- hallmark= Reed-Sternberg cell with mirror- image nuclei, 90-95%
Nodular lymphocyte predominant HL (NLPHL)= Reed-Sternberg VARIANT, ‘popcorn cell’
Risk factors for HL? Clinical presentation?
Affected sibling, EBV, SLE, obese, post-transplantation
Painless groin lymphadenopathy, young women= cough due to mediastinal lymphadenopathy
B symptoms= weight loss, fever, night sweats
Emergency= infection, SVC obstruction with increased JVP, sensation of fullness in head, dyspnoea, blackouts, facial oedema
Diagnosis of HL?
CT/MRI of chest, abdomen and pelvis for staging (Ann Arbor), lymph node excision/ bone marrow biopsy- popcorn cells
Bloods: high ESR or low Hb- worse prognosis
Immunophenotyping, cytogenetics, PET scan
Staging of HL (Ann Arbor)? Each stage what or what?
I= confined to single lymph node region, II= two or more nodal areas on same side of diaphragm, III= nodes on both sides of diaphragm, IV= spread beyond lymph nodes e.g. liver/ bone marrow
A or B- A= no systemic symptoms other than pruritus (severe itching of skin,)
B= B symptoms- fever, weight loss and night sweats
Treatment of HL? Complications of radio and chemotherapy?
Combination chemotherapy- ABVD: A- adriamycin, B- bleomycin, V- vinblastine, D- dacarbazine
I-A to II-A= short course ABVD followed by RT
II-A to IV-B= longer course ABVD
Radio= increases risk of second malignancies- solid tumours esp in lung, breast, melanoma, stomach, sarcoma and thyroid, increased risk of IHD, hypothyroidism and lung fibrosis
Chemo= myelosuppression, nausea, alopecia and infection, infertility
Epidemiology and risk factor for N-HL?
All lymphomas without Reed-Sternberg cells, around 80%= B-cell origin, diffuse large B-cell= commonest, 20%= T-cell
More varied in terms of presentation, sub-types, treatments and outcomes, not all centre on nodes, strong link with EBV and Burkitts lymphoma
Family history= minor increase in risk
Presentation of N-HL?
Nodal disease (75%) e.g. superficial lymphadenopathy
Extranodal (25%): skin- esp T-cell lymphoma, oropharynx, gut, small bowel, bone, CNS and lungs
Systemic B symptoms
Pancocytopenia- anaemia, infection and bleeding
N-HL classified into what 2 grades? Presents and curable?
Low/indolent grade- e.g. follicular, slow growing, usually advanced at presentation, incurable, median survival= 9-11 years
High grade- e.g. diffuse large B-cell, usually nodal presentation, 1/3 cases have extra nodal involvement
Diagnosis of N-HL?
Raised lactose dehydrogenase= worse prognosis, lymph node excision/ bone marrow biopsy- not see R-S cells/ popcorn cells
Marrow and node biopsy for classification, CT/MRI of chest, abdomen and pelvis for staging, immunophenotyping, cytogenetics
Treatment of N-HL?
R-CHOP regimen: R- rituximab (MAb- minimal side effects) C- cyclophosphamide H-hydroxy-daunorubicin O-vincristine (oncovin brand) P-prednisolone
Rituximab targets what? Treatment for grades of N-HL? What is Burkitts lymphoma?
MAb targeting CD20 expressed on B cell surface
Low grade= none may be needed, radio may be curative in localised disease
High grade= early- 3 months R-CHOP with radiotherapy, late= 6 months R-CHOP regimen with radiotherapy
Usually B cells with jaw lymphadenopathy in children
Epidemiology of myeloma?
Cancer of differentiated B lymphocytes known as plasma cells, accumulation of malignant plasma cells in bone marrow–> progressive bone marrow failure
Produce excess of one type of Ig= monoclonal paraprotein
IgG(55%), IgA(20%), rarely IgM and IgD
Others= low–> immunoparesis, bone disease, hypercalcaemia, renal failure
Peak age= 70 years, more common in Afro-Caribeeans than caucasians
Clinical presentation of myeloma? 2 things activate osteoclasts? Inhibiting osteoblasts?
OLD CRAB
Old age, calcium elevated, renal failure- nephrotic syndrome, Igs deposit in organs–> thirst from kidneys, anaemia- neutropenia or thrombocytopenia, bone lytic lesions- back pain= osteoclasts activated–> increased breakdown and lytic lesions
RANK ligand and IL-3
HGF and Dkk-1
Recurrent bacterial infections due to neutropenia, healthy= may cause high neutrophil count
Diagnosis of myeloma? Diagnosis requires?
Blood: normocytic normochromic anaemia, raised ESR, Rouleaux formation on blood film
U&Es= high calcium, high alkaline phosphatase, Bence-jones protein in urine
PLAIN X-ray- lytic ‘punched out lesions: pepper-pot skull, vertebral collapse
Serum and urine electrophoresis- B2- macro globulin present and prognostic, fractures and osteoporosis
Monoclonal protein band in serum or urine, increased plasma cells on bone marrow biopsy, hypercalcaemia/ renal failure/ anaemia, bone lesions on skeletal survey
Treatment of myeloma?
Bone pain= analgesia, avoid NSAIDs due to renal risk
Bisphosphonates e.g. zolendronate- reduce fracture rates and bone pain
Anaemia= RBC transfusion and erythropoietin
Rehydration of 3L/day
Renal dialysis- treat acute renal failure
Broad-spectrum antibiotics to treat infections quickly
Chemo= CTD- cyclophosphamide, thalidomide and dexamethasone, max 8 cycles for less fit people
VAD- in fitter people, max 6 cycles
Stem cell transplant
4 main subtypes of leukaemia? What is leukaemia?
Acute lymphoblastic, acute myeloid (AML,) chronic myeloid (CML,) and chronic lymphocytic (CLL)
Presence of rapidly proliferating immature blast blood cells (can be pre-cursors of RBCs, platelets or white cells) in bone marrow that are non functional i.e. defective
2 issues posed by leukaemia? Age of leukaemia in general?
Dividing rapidly but serve no function, so wasting energy, less available for making useful functional cells
Due to rapid replication, these cells take up lot of space within bone marrow, meaning little space and also food for other cells to grow
When no space in BM, leukaemia cells will be present in blood too
At any age, type varies with age, all mainly seen in childhood and CLL= elderly disease
Epidemiology of acute myeloid leukaemia (AML)?
Neoplastic proliferation of blast cells derived from marrow myeloid–> basophils, neutrophils and eosinophils
Progresses rapidly with death in 2 months if untreated, commonest acute leukaemia of adults
Associated with radiation and syndromes such as Down’s
Clinical presentation of acute myeloid leukaemia?
Marrow failure: anaemia- low Hb: breathlessness, fatigue, angina and claudication, pallor, cardiac flow murmur
Infection- low WCC–> infections, fever, mouth ulcers
Bleeding- low platelets–> bleeding and bruising
Hepatomegaly and splenomegaly due to infiltration, gum hypertrophy, DIC occurs in subtype of AML where release of thromboplastin
Diagnosis and complications of acute myeloid leukaemia?
WCC often raised, but can be normal/ low, may be few blast cells in peripheral blood so diagnosis depends on bone marrow biopsy, differentiation from all based on: immunophenotyping and molecular methods
Infection- alert to septicaemia, causes common organisms to present oddly, with few antibodies being made
Treatment for AML?
Blood and platelet transfusions, neutropenia= prophylactic antivirals, antibacterial and antifungals, allopurinol- prevents tumour lysis syndrome, IV fluids- Hickman line, chemotherapy, marrow transplantation
Epidemiology of chronic myeloid leukaemia (CML)?
Most exclusively disease of adults, uncontrolled clonal proliferation of myeloid cells, occurs most often between 40-60 years, slight male predominance, rare in childhood, more than 80%= Philadelphia chromosome forms fusion gene BCR/ ABL on chromosome 22= tyrosine kinase activity stimulating cell division
Clinical presentation of CML?
Symptomatic anaemia e.g. SOB, abdominal discomfort due to splenomegaly, weight loss, tiredness, pallor, fever and sweats in absence of infection, features of gout due to purine breakdown, bleeding due to platelet dysfunction
Diagnosis of CML? Treatment of CML?
Blood count: very high WCC- whole spectrum of myeloid cells i.e. increased; neutrophils, myelocytes, basophils and eosinophils, low Hb- normochromic and normocytic, low platelets or normal or raised, bone marrow aspirate: hyper cellular (increased cells)
Oral imatinib- specific BCR/ABL tyrosine kinase inhibitor, stem cell transplant
Epidemiology of chronic lymphocytic leukaemia (CLL)?
Most common leukaemia, occurs predominantly in later life, accumulation of mature B cells escaped programmed cell death and undergone cell-cycle arrest
Mutations, trisomies and deletions influence risk, pneumonia may be triggering event
Clinical presentation of CLL?
Often no symptoms, presenting as surprised on routine FBC, may be anaemic or infection prone, severe= weight loss, sweats and anorexia, hepatosplenomegaly, enlarged rubbery, non-tender nodes
Diagnosis and complications of CLL?
Normal or low Hb, raised WCC with very high lymphocytes, blood film: smudge cells may be seen in vitro
Autoimmune haemolysis- increased infection risk due to low IgG; bacterial and viral especially herpes zoster, marrow failure
Progression and prognosis of CLL? Tx?
Many stable for years and may even regress, death= often due to complication of infection, may transform–> aggressive lymphoma= Richter’s syndrome
1/3 will never progress, 1/3 progress slowly, 1/3 progress actively
Blood transfusions, human IV IGs, chemotherapy or radiotherapy, stem cell transplant
What is anaemia?
Decrease in Hb in the blood below reference level for age and sex of individual
Either due to low red cell mass (RCM) or increased plasma volume
May be due to reduced production from BM or increased loss of RBCs by spleen, liver, BM and blood loss and has many causes